Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Research on Beta-Glucans Published in Nature - Nutraceuticals World
Research

Research on Beta-Glucans Published in Nature

A new study published in the journal Nature features Biothera’s beta-glucans and new discoveries regarding how these immunodulating compounds prime the innate immune system to protect the body.

This research confirmed that not all beta-glucans are alike. Led by David Underhill, PhD, researchers demonstrated that beta-glucan size and molecular structure is critical to receptor binding and the resulting innate immune cell response. Dr. Underhill and his research team found that specific beta-glucan structures bind to a particular receptor (Dectin-1) while other beta-glucans structures may not.

The study shows that Dectin-1 distinguishes between direct microbial contact and detection of microbes at a distance, a distinction that enables effective microbial killing responses.  When bound to Biothera’s Wellmune WGP, Dectin-1 signaling primed immune cells for phagocytosis, a mechanism used to recognize and destroy pathogens.

“This research was possible because of Biothera’s capability to isolate, modify and characterize these beta-glucan compounds,” said Dr. Underhill, associate professor, IBD and Immunobiology Research Institute, Cedars-Sinai Medical Center. For further information: www.biothera.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters